71
Participants
Start Date
November 30, 2008
Primary Completion Date
June 30, 2010
Study Completion Date
October 31, 2013
Macrolane VRF30
Device: Macrolane VRF30 (stabilized hyaluronic acid of non-animal origin) Treatment: Initial injection of a maximum of 120 ml/breast. Re-injection of a maximum of 120 ml/breast in a subgroup of subjects.
Sainte Anne, Paris
L'Institute du Sein, Paris
Plastikkirurggruppen, Stockholm
Akademikliniken, Stockholm
Proforma Clinic, Stockholm
Lead Sponsor
Galderma R&D
INDUSTRY